Медико-биологический
информационный портал
для специалистов
 
Medline.ru

СОДЕРЖАНИЕ ЖУРНАЛА:
Физико-химическая биология

Клиническая медицина

Профилактическая медицина

Медико-биологические науки


АРХИВ:

Фундаментальные исследования

Организация здравохраниения

История медицины и биологии



Последние публикации

Поиск публикаций

Articles

Архив :  2000 г.  2001 г.  2002 г. 
               2003 г.  2004 г.  2005 г. 
               2006 г.  2007 г.  2008 г. 
               2009 г.  2010 г.  2011 г. 
               2012 г.  2013 г.  2014 г. 
               2015 г.  2016 г.  2017 г. 
               2018 г.  2019 г.  2020 г.  2021 г.  2022 г.  2023 г. 

Редакционная информация:
        Опубликовать статью
        Наша статистика


 РЕДАКЦИЯ:
Главный редактор

Заместители главного редактора

Члены редколлегии
Специализированные редколлегии


 УЧРЕДИТЕЛИ:
Институт теоретической и экспериментальной биофизики Российской академии наук.

ООО "ИЦ КОМКОН".




Адрес редакции и реквизиты

199406, Санкт-Петербург, ул.Гаванская, д. 49, корп.2

ISSN 1999-6314

Российская поисковая система
Искать: 


«
Vol. 18, Art. 38 (pp. 561-571)    |    2017       
»

Immunohistochemical study of Ki-67 in various adenomas of the pituitary gland depending on their hormonal profile.
Vorobyova O.M., Ryazanov P.A., Konovalov P.V., Mitrofanova L.B.

Federal State Budgetary Institution Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russia, 197341



Brief summary

The search for prognostic criteria in oncology is one of the key areas of research. A significant role in this is assigned to the morphological and immunohistochemical criteria. Objective: to evaluate Ki-67 as a prognostic factor for various adenomas of the pituitary gland, depending on their hormonal profile. Materials and methods: analysis of surgical material and medical documentation of 142 patients with pituitary adenomas. A standard histological study was carried out with the staining of hematoxylin and eosin and an immunohistochemical study with antibodies to ki-67 and 6 hormones of adenohypophysis: prolactin, adrenocorticotropic hormone (ACTH), growth hormone (GH), thyroid-stimulating hormone (TSH), follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Results: macroadenomas predominated over the microadenomas, and in both this groups, mammosomatotropinomas predominated. There were no significant differences in ki-67 between macroadenomas and microadenomas. Recurrent adenomas were larger than non-recurring, but no significant differences in ki-67 levels between this two groups were detected. Adenomas with invasion were larger and had higher values of ki-67 than formations without infestation. The index of proliferative activity of ki-67 of more than 2.6% can be estimated as prognostic criterion of invasive growth only for gonadotropinomas. Conclusion: The role of ki-67 as a prognostic criterion for pituitary adenomas is very limited, both according to our research, and according to the data of foreign authors.


Key words

hormonal types of the pituitary adenoma, prognostic factors, immunohistochemical study, Ki-67.





(The article in PDF format. For preview need Adobe Acrobat Reader)



Open article in new window

Reference list

1) DeLellis R.A, Lloyd R.V., Heitz P.U., Eng C. World Health Organization Classification of Tumors. Pathology and Genetics Numors of Endocrine Organs. IARC Press: Lyon, 2004. - 320 p.


2) Lloyd R.V., Osamura, R.Y., Klöppel G., Rosai J. WHO Classification of Tumors of Endocrine Organs. 4th ed., IARC Press: Lyon, 2017. - 355 p.


3) Ylitin A.U. Gigantskie adenomi gipofiza osobennosti kliniki i techeniya. Avtoref. dis. d. med. nayk - SPb, 2008. - 45 s.


4) Salehi F., Agur A., Scheithauer B.W. et al. Ki-67 in pituitary neoplasms: a review--part I . Neurosurgery. 2009; 65(3): 429-37.


5) Sav A., Rotondo F., Syro L.V. et al. Biomarkers of pituitary neoplasms. Anticancer Res. 2012; 32(11): 4639-54.


6) Zakir J.O., Casulari L.A., Rosa J.W. et al. Prognostic Value of Invasion, Markers of Proliferation, and Classification of Giant Pituitary Tumors, in a Georeferred Cohort in Brazil of 50 Patients, with a Long-Term Postoperative Follow-Up. Int J Endocrinol. 2016; 2016: 7964523.


7) Ozer, E. Expression of BCL-2, BAX and p53 proteins in pituitary adenomas: An immunohistochemical study / E. Ozer, M.S. Canda, C. Ulukus [et al.] // Tumori. - 2003. - Vol. 89, iss. 1. -P. 54-59.


8) Witek P., Zielinski G., Szamotulska K. et al. Clinicopathological predictive factors in the early remission of corticotroph pituitary macroadenomas in a tertiary referral centre. Eur J Endocrinol. 2016;174(4): 539-49.


9) Aguiar P.H., Aires R., Laws E.R. et al. Labeling index in pituitary adenomas evaluated by means of MIB-1: is there a prognostic role? A critical review. Neurol Res. 2010; 32(10): 1060-71.


10) Raverot G., Vasiljevic A., Jouanneau E. et al. A prognostic clinicopathologic classification of pituitary endocrine tumors. Endocrinol Metab Clin North Am. 2015; 44(1): 11-8.


11) Trouillas J., Roy P., Sturm N. et al. A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol. 2013;126(1): 123-35.


12) Korbonits M., Chahal?H.S., Kaltsas G. et al. Expression of phosphorylated p27(KIP1) protein and JUN activation domain-binding protein 1 in human pituitary tumors. J Clin Endocrinol Metab. 2002; 87(6): 2635-2643.


13) Bloomer C.W., Kenyon L, Hammond E, Hyslop T. Cyclooxygenase-2 (COX-2) and epidermal growth factor receptor (EGFR) expression in human pituitary macroadenomas. Am J Clin Oncol. 2003; 26(4): 75-80.


14) Riss D., Jin L., Qian X. et al. Differential expression of galectin-3 in pituitary tumors. Cancer Res. 2003;63(9): 2251-2255.


15) Filippella M., Galland F., Kujas M. et al. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study. Clin Endocrinol (Oxf). 2006; 65(4): 536-543.


16) Fukui S., Nawashiro H., Otani N. et al.Vascular endothelial growth factor expression in pituitary adenomas. Acta Neurochir Suppl. 2006;86: 519-521.



Свидетельство о регистрации сетевого электронного научного издания N 077 от 29.11.2006
Журнал основан 16 ноября 2000г.
Выдано Министерством РФ по делам печати, телерадиовещания и средств массовых коммуникаций
(c) Перепечатка материалов сайта Medline.Ru возможна только с письменного разрешения редакции

Размещение рекламы

Rambler's Top100